Track topics on Twitter Track topics that are important to you
The decision marks Novocure's first national coverage policy Novocure (NASDAQ: NVCR) announced today it has signed a contract with the Federation of the Austrian Social Insurance Institutions whic...
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2017 on Thursday, July 27, 2017, before the U.S.-based financial markets open....
The first patient in a Phase II pilot study of a combination of Novocure's Optune tumor-treating fields delivery device and R -More-
Novocure has obtained a humanitarian use device designation from the FDA for its Tumor Treating Fields delivery system for us -More-
Novocure (NASDAQ: NVCR) gab heute bekannt, dass auf dem Kongress der Europäischen Gesellschaft für Medizinische Onkologie 2017 (European Society for Medical Oncology, ESMO) vom 8. bis zum 12. Sept.....
Late-breaking oral presentation to focus on Optune five-year survival and health-related quality of life data Novocure (NASDAQ:NVCR) announced today four presentations on Tumor Treating Fields (TT...
Monday, May 15th 2017 at 11:25am UTC ST. HELIER, Jersey–(BUSINESS WIRE)– Novocure (NASDAQ:NVCR) announced today that United States Food and Drug Administration (FDA) has designated it’s ...
Late-breaking oral presentation to focus on Optune five-year survival and health-related quality of life data ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ:NVCR) announced today...
This protocol is designed to generate and provide preliminary data to determine the safety and activity of combination therapy using tumor treating fields (TTFields; Optune(NovoTTF-100A); ...
Glioblastoma multiforme (GBM) is the most common and deadliest primary malignant neoplasm of the central nervous system in adults. Despite an aggressive multimodality treatment approach in...
Novocure is a private Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocure US operations are based in Portsmouth, NH and New York, NY...
NovoCure Limited is a private Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocureâs US operations are based in Portsmouth, NH a...
We have published hundreds of NovoCure, Ltd. news stories on BioPortfolio along with dozens of NovoCure, Ltd. Clinical Trials and PubMed Articles about NovoCure, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovoCure, Ltd. Companies in our database. You can also find out about relevant NovoCure, Ltd. Drugs and Medications on this site too.